- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Veterinary Medicines Regulations 2006, Paragraph 6.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
6. The following table sets out the fees relating to a pharmaceutical veterinary medicinal product for—
(a)a national application for a marketing authorisation that is—
(i)a full application under Part 1 of Schedule 1;
(ii)a bibliographic application; or
(iii)an application based on pharmacological equivalence;
(b)an application for a marketing authorisation using the decentralised procedure where the United Kingdom is a concerned member State;
(c)an application for the mutual recognition of a product authorised in another member State.
Pharmacologically equivalent national application | |||||
---|---|---|---|---|---|
Menu | Full national application under Part 1 of Schedule 1 (£) | Bibliographic national application (£) | Reference product authorised in UK (£) | Reference product not authorised in UK (£) | Decentralised application where the UK is a concerned member State or recognition of a product authorised in another member State (£) |
Base Fee: The following fees are in addition to the base fee— | 910 | 1,800 | 1,800 | 2,320 | 460 |
Quality assessment (if quality data are assessed): | 3,810 | 3,230 | 2,710 | 3,470 | 1,810 |
Safety assessment (if safety data are assessed): | 3,810 | 3,030 | 1,030 | 1,330 | 1,810 |
Efficacy assessment (if efficacy data are assessed): | 3,810 | 3,030 | 1,030 | 1,330 | 1,810 |
Ecotoxicology assessment (if ecotoxicology data are assessed): | 640 | 520 | 320 | 410 | 390 |
Additional fee if any of the target species is a food-producing animal (not payable if neither safety data nor ecotoxicology data are assessed): | 3,740 | 3,420 | 2,070 | 2,650 | 1,350 |
Reduced by— | |||||
| 2,100 | 2,100 | 1,290 | 1,650 | 640 |
| 990 | 760 | 290 | 370 | 290 |
Additional fee for each active ingredient not previously included in a veterinary medicinal product authorised in the United Kingdom— | |||||
| 7,170 | 6,330 | 5,610 | 7,200 | 2,520 |
| 6,260 | 5,620 | 5,360 | 6,870 | 2,200 |
Additional fee for each additional pack type: | 720 | 720 | 590 | 740 | 330 |
Reduced by— | |||||
| 350 | 350 | 350 | 450 | 120 |
| 180 | 180 | 120 | 150 | 60 |
| 60 | 60 | 60 | 70 | 60 |
| 60 | 60 | — | — | 60 |
Additional fee for each additional active ingredient (food-producing animal): | 6,210 | 5,870 | 3,880 | 4,960 | 2,000 |
Reduced by— | |||||
| 1,400 | 1,400 | 1,400 | 1,790 | 470 |
| 2,630 | 2,630 | 1,580 | 2,020 | 820 |
| 880 | 700 | 530 | 670 | 290 |
| 700 | 580 | — | — | 230 |
Additional fee for each additional active ingredient (non-food-producing animal): | 4,140 | 3,940 | 3,110 | 3,960 | 1,430 |
Reduced by— | |||||
| 1,400 | 1,400 | 1,400 | 1,790 | 470 |
| 1,400 | 1,400 | 880 | 1,120 | 470 |
| 880 | 700 | 530 | 670 | 290 |
| 60 | 60 | — | — | 60 |
Additional fee if there is more than one target species, for each additional species (food-producing animal): | 3,820 | 3,430 | 2,330 | 2,980 | 1,240 |
Reduced by— | |||||
| 180 | 180 | 180 | 220 | 60 |
| 1,400 | 1,400 | 880 | 1,120 | 470 |
| 1,750 | 1,400 | 1,050 | 1,350 | 530 |
| 120 | 120 | — | — | 60 |
Additional fee if there is more than one target species, for each additional species (non-food-producing animal): | 2,400 | 2,010 | 1,490 | 1,900 | 780 |
Reduced by— | |||||
| 180 | 180 | 180 | 220 | 60 |
| 180 | 180 | 120 | 150 | 60 |
| 1,750 | 1,400 | 1,050 | 1,350 | 530 |
| 60 | 60 | — | — | 60 |
Additional fee for each additional recommended route of administration (food-producing animal): | 2,590 | 2,390 | 1,560 | 1,980 | 910 |
Reduced by— | |||||
| 1,400 | 1,400 | 880 | 1,120 | 470 |
| 880 | 700 | 530 | 670 | 290 |
| 60 | 60 | — | — | 60 |
Additional fee for each additional recommended route of administration (non- food-producing animal): | 1,170 | 970 | 720 | 910 | 390 |
Reduced by— | |||||
| 180 | 180 | 120 | 150 | 60 |
| 880 | 700 | 530 | 670 | 290 |
Simultaneous applications: fee for each additional product in the application: | 2,780 | 2,780 | 2,780 | 3,560 | 1,610 |
Commencement Information
I1Sch. 7 para. 6 in force at 1.10.2006, see reg. 1
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: